Pulmonology

Prof. Dr. Yelda Varol

Doctor and researcher İzmir Şehir Hastanesi İzmir
COVID-19Lung NeoplasmsHypertension, PulmonaryPulmonary Embolism
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • COVID-19 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 2 publications
  • Hypertension, Pulmonary 2 publications
  • Pulmonary Embolism 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPulmonologysaglik.gov.trFrom source
  • Department name at the sourceGöğüs Hatalıklarısaglik.gov.trFrom source
  • Institutionİzmir Şehir Hastanesisaglik.gov.trFrom source
  • Area of workCOVID-19Extracted from 3 publications · Model version —From source
  • Publications102 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0003-4604-7173ORCIDFrom source
  • Last synchronised5 November 2026 09:07https://izmirsehir.saglik.gov.tr/TR-1046714/doktorlarimiz.html#yelda-varolsaglik.gov.tr

Scientific work

Publications on COVID-19

102 publications
Publications by year Most: 15, in 2026
  1. 2008: 1 publication
  2. 2009: 0 publications
  3. 2010: 0 publications
  4. 2011: 1 publication
  5. 2012: 3 publications
  6. 2013: 3 publications
  7. 2014: 6 publications
  8. 2015: 4 publications
  9. 2016: 7 publications
  10. 2017: 6 publications
  11. 2018: 5 publications
  12. 2019: 8 publications
  13. 2020: 8 publications
  14. 2021: 8 publications
  15. 2022: 3 publications
  16. 2023: 5 publications
  17. 2024: 7 publications
  18. 2025: 12 publications
  19. 2026: 15 publications

  1. Validation and Reliability Assessment of the Test of Adherence to Inhalers (TAI) in Turkish Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Thoracic research and practice, 2026

    DOI 10.4274/thoracrespract.2026.2026-1-5 PMID 41979103 Open-access full textSource: OpenAlex

  2. Inhaler-specific drug therapy problems in COPD

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa2577 Source: OpenAlex

  3. Polypharmacy in COPD and Its Impact on Clinical Outcomes

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa5825 Source: OpenAlex

  4. Predictors of 90-Day Mortality and the Association of Reperfusion Therapy with 90-Day Mortality in Intermediate-High and High-Risk Pulmonary Embolism: A Real-World Multidisciplinary Cohort Study

    Life, 2026

    DOI 10.3390/life16071189 PMID 42514256 Open-access full textSource: ORCID

  5. Rare Interstitial Lung Diseases in the Elderly: A Different Spectrum?

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3089 Source: OpenAlex

  6. Clinical heterogeneity and progression risk in pulmonary alveolar microlithiasis: a multicenter real-world cohort

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa891 Source: OpenAlex

  7. Lymphangioleiomyomatosis in Türkiye: Real-World Data from the TRILD Registry

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa5268 Source: OpenAlex

  8. Sex Differences in Clinical Presentation and Outcomes in Acute Pulmonary Embolism: A Nationwide Multicenter Study

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa1376 Source: OpenAlex

  9. B67-20 Thrombolysis and 90-Day Mortality in High- And Intermediate-High-Risk Pulmonary Embolism: A Real-World Cohort Study

    American Journal of Respiratory and Critical Care Medicine, 2026

    DOI 10.1093/ajrccm/aamag162.5721 Source: OpenAlex

  10. Late-Onset Nivolumab-Induced Pneumonitis in Metastatic Lung Adenocarcinoma: A Case Report

    Journal of İzmir Chest Hospital, 2026

    DOI 10.14744/igh.2026.06977 Open-access full textSource: OpenAlex

View all 102 publications